在 COVID-19 中的超声心动图、肺部超声和心脏磁共振成像的发现：一项系统性综述。
Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.
机构信息
Department of Internal Medicine, Rochester Regional Health, Unity Hospital, Rochester, New York, USA.
Department of Internal Medicine, Canton Medical Education Foundation, Canton, Ohio, USA.
出版信息
Echocardiography. 2021 Aug;38(8):1365-1404. doi: 10.1111/echo.15152. Epub 2021 Jul 8.
Abstract
BACKGROUND
The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described.
METHODS
We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were included.
RESULTS
This review describes the most common abnormalities encountered on echocardiography, LUS, and CMR in patients infected with COVID-19.
摘要
背景
影像学检查（如超声心动图、肺部超声[LUS]和心脏磁共振成像[CMR]）对 COVID-19 的表现的描述并不全面。
方法
我们对当前文献进行了系统综述，并纳入了使用超声心动图、CMR 描述 COVID-19 心血管表现以及使用 LUS 描述肺部表现的研究。我们在 PubMed、EMBASE 和 Web of Science 中查询了相关文章。纳入了原始研究和病例系列。
结果
本综述描述了 COVID-19 患者在超声心动图、LUS 和 CMR 上最常见的异常表现。
相似文献
1
Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.
Echocardiography. 2021 Aug;38(8):1365-1404. doi: 10.1111/echo.15152. Epub 2021 Jul 8.
2
Ultrasound findings of lung ultrasonography in COVID-19: A systematic review.
Eur J Radiol. 2022 Mar;148:110156. doi: 10.1016/j.ejrad.2022.110156. Epub 2022 Jan 20.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Measures implemented in the school setting to contain the COVID-19 pandemic.
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
5
Inhaled corticosteroids for the treatment of COVID-19.
Cochrane Database Syst Rev. 2022 Mar 9;3(3):CD015125. doi: 10.1002/14651858.CD015125.
6
Early spontaneous breathing for acute respiratory distress syndrome in individuals with COVID-19.
Cochrane Database Syst Rev. 2022 Jun 29;6(6):CD015077. doi: 10.1002/14651858.CD015077.
7
Thoracic imaging tests for the diagnosis of COVID-19.
Cochrane Database Syst Rev. 2022 May 16;5(5):CD013639. doi: 10.1002/14651858.CD013639.pub5.
8
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
9
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
10
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
引用本文的文献
1
Subclinical patterns of cardiac involvement by transthoracic echocardiography in individuals with mild initial COVID-19.
Sci Rep. 2025 Jan 30;15(1):3772. doi: 10.1038/s41598-025-85221-w.
2
Lung Ultrasonography in the Evaluation of Late Sequelae of COVID-19 Pneumonia-A Comparison with Chest Computed Tomography: A Prospective Study.
Viruses. 2024 Jun 3;16(6):905. doi: 10.3390/v16060905.
3
COVID-19 Associated Cardiovascular Disease-Risks, Prevention and Management: Heart at Risk Due to COVID-19.
Curr Issues Mol Biol. 2024 Feb 29;46(3):1904-1920. doi: 10.3390/cimb46030124.
4
Sequence and directivity in cardiac muscle injury of COVID-19 patients: an observational study.
Front Cardiovasc Med. 2023 Oct 16;10:1260971. doi: 10.3389/fcvm.2023.1260971. eCollection 2023.
5
Lung Ultrasound in Predicting Outcomes in Patients with COVID-19 Treated with Extracorporeal Membrane Oxygenation.
Viruses. 2023 Aug 24;15(9):1796. doi: 10.3390/v15091796.
6
Impact of COVID-19 vaccination in post-COVID cardiac complications.
Vaccine. 2023 Feb 17;41(8):1524-1528. doi: 10.1016/j.vaccine.2023.01.052. Epub 2023 Jan 27.
7
Role of cardiovascular magnetic resonance imaging in COVID-19 recovered patients: A short-term follow-up study.
Echocardiography. 2022 Nov;39(11):1401-1411. doi: 10.1111/echo.15466. Epub 2022 Oct 20.
8
Time course of lung ultrasound findings in patients with COVID-19 pneumonia and cardiac dysfunction.
Ultrasound J. 2022 Jul 7;14(1):28. doi: 10.1186/s13089-022-00278-2.
9
Long-term cardio-vascular risk assessment in chronic kidney disease and kidney transplanted patients following SARS-COV-2 disease: protocol for multi-center observational match controlled trial.
BMC Nephrol. 2022 May 6;23(1):176. doi: 10.1186/s12882-022-02809-4.
10
Ultrasound findings of lung ultrasonography in COVID-19: A systematic review.
Eur J Radiol. 2022 Mar;148:110156. doi: 10.1016/j.ejrad.2022.110156. Epub 2022 Jan 20.
本文引用的文献
1
SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes.
Circulation. 2021 Jul 27;144(4):256-266. doi: 10.1161/CIRCULATIONAHA.121.054824. Epub 2021 Apr 17.
2
Alterations of Left Ventricular Function Persisting during Post-Acute COVID-19 in Subjects without Previously Diagnosed Cardiovascular Pathology.
J Pers Med. 2021 Mar 22;11(3):225. doi: 10.3390/jpm11030225.
3
Echocardiographic Characteristics and Outcome in Patients With COVID-19 Infection and Underlying Cardiovascular Disease.
Front Cardiovasc Med. 2021 Mar 16;8:642973. doi: 10.3389/fcvm.2021.642973. eCollection 2021.
4
Subclinical left ventricular dysfunction in COVID-19.
Int J Cardiol Heart Vasc. 2021 Jun;34:100770. doi: 10.1016/j.ijcha.2021.100770. Epub 2021 Mar 24.
5
Acute pulmonary hypertension and short-term outcomes in severe Covid-19 patients needing intensive care.
Acta Anaesthesiol Scand. 2021 Jul;65(6):761-769. doi: 10.1111/aas.13819. Epub 2021 Mar 27.
6
Evaluation of left ventricular global functions with speckle tracking echocardiography in patients recovered from COVID-19.
Int J Cardiovasc Imaging. 2021 Jul;37(7):2227-2233. doi: 10.1007/s10554-021-02211-5. Epub 2021 Mar 16.
7
Cardiac Abnormalities in COVID-19 and Relationship to Outcome.
Mayo Clin Proc. 2021 Apr;96(4):932-942. doi: 10.1016/j.mayocp.2021.01.006. Epub 2021 Jan 19.
8
Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening.
JAMA Cardiol. 2021 Jul 1;6(7):745-752. doi: 10.1001/jamacardio.2021.0565.
9
Prognostic Value of Right Ventricular Ejection Fraction Assessed by 3D Echocardiography in COVID-19 Patients.
Front Cardiovasc Med. 2021 Feb 9;8:641088. doi: 10.3389/fcvm.2021.641088. eCollection 2021.
10
Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance.
J Cardiovasc Magn Reson. 2021 Feb 25;23(1):14. doi: 10.1186/s12968-021-00710-x.
Zotero 插件